Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1930) 1930
Publication (115) 115
Book Review (53) 53
Book Chapter (13) 13
Conference Proceeding (3) 3
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1232) 1232
index medicus (847) 847
chemotherapy-induced nausea (807) 807
oncology (777) 777
female (757) 757
male (659) 659
chemotherapy (641) 641
middle aged (623) 623
cancer (614) 614
nausea - chemically induced (569) 569
nausea (546) 546
vomiting - chemically induced (522) 522
double-blind (517) 517
adult (506) 506
aged (492) 492
prevention (443) 443
antineoplastic agents - adverse effects (434) 434
chemotherapy-induced nausea and vomiting (412) 412
antiemetics - therapeutic use (387) 387
vomiting (378) 378
pharmacology & pharmacy (348) 348
vomiting - prevention & control (324) 324
antineoplastic combined chemotherapy protocols - adverse effects (322) 322
antineoplastic combined chemotherapy protocols - therapeutic use (298) 298
nausea - prevention & control (293) 293
medicine & public health (281) 281
aprepitant (259) 259
dexamethasone (250) 250
neoplasms - drug therapy (236) 236
health care sciences & services (230) 230
palonosetron (226) 226
ondansetron (224) 224
care and treatment (218) 218
placebo-controlled trial (216) 216
moderately emetogenic chemotherapy (215) 215
nursing (215) 215
antiemetics (214) 214
vomiting - drug therapy (214) 214
nausea - drug therapy (202) 202
efficacy (195) 195
animals (193) 193
quality of life (187) 187
quality-of-life (183) 183
rehabilitation (182) 182
treatment outcome (181) 181
analysis (175) 175
cisplatin - adverse effects (174) 174
cisplatin (164) 164
antiemetics - administration & dosage (163) 163
emesis (161) 161
pain medicine (161) 161
drug administration schedule (151) 151
rehabilitation medicine (147) 147
health aspects (143) 143
aged, 80 and over (135) 135
cisplatin-induced emesis (133) 133
cisplatin - administration & dosage (132) 132
research (129) 129
granisetron (127) 127
antineoplastic agents - therapeutic use (122) 122
complications and side effects (122) 122
drug therapy (121) 121
phase-iii (119) 119
clinical trials (115) 115
gastrointestinal agents (114) 114
risk factors (114) 114
safety (113) 113
young adult (112) 112
adolescent (111) 111
breast neoplasms - drug therapy (108) 108
patients (106) 106
prospective studies (105) 105
therapy (104) 104
antiemetics - adverse effects (103) 103
breast cancer (103) 103
induced emesis (103) 103
pain (103) 103
cancer patients (102) 102
cancer therapies (102) 102
drug therapy, combination (102) 102
hematology (102) 102
high-dose cisplatin (102) 102
nursing management/nursing research (99) 99
chemotherapy-induced emesis (98) 98
prophylaxis (97) 97
receptor antagonist (97) 97
breast-cancer (96) 96
double-blind method (96) 96
trial (94) 94
morpholines - therapeutic use (92) 92
dose-response relationship, drug (91) 91
management (89) 89
dexamethasone - therapeutic use (88) 88
serotonin antagonists - therapeutic use (88) 88
cancer-patients (87) 87
pharmacokinetics (86) 86
antiemetics - pharmacology (83) 83
nausea - etiology (83) 83
delayed emesis (82) 82
dosage and administration (82) 82
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1625) 1625
Japanese (182) 182
Chinese (72) 72
French (26) 26
German (23) 23
Spanish (6) 6
Hungarian (2) 2
Korean (2) 2
Italian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Anticipatory nausea and vomiting
by Roscoe, Joseph A and Morrow, Gary R and Aapro, Matti S and Molassiotis, Alexander and Olver, Ian
Supportive Care in Cancer, ISSN 0941-4355, 10/2011, Volume 19, Issue 10, pp. 1533 - 1538
A commonly reported consequence of post-treatment nausea or vomiting is the development of anticipatory nausea and vomiting (ANV). In most published work,... 
Anticipatory nausea and vomiting | Pain Medicine | Nursing | Rehabilitation Medicine | Medicine & Public Health | Oncology | Nursing Management/Nursing Research | ADJUVANT CHEMOTHERAPY | LITHIUM-PAIRED CONTEXT | CHEMOTHERAPY-INDUCED NAUSEA | ACUPUNCTURE | SUNCUS-MURINUS | PREVENTION | SYMPTOMS | ONCOLOGY | HEALTH CARE SCIENCES & SERVICES | BREAST-CANCER PATIENTS | REHABILITATION | ANIMAL-MODEL | EMESIS | Vomiting, Anticipatory - therapy | Nausea - chemically induced | Vomiting, Anticipatory - etiology | Humans | Antineoplastic Agents - therapeutic use | Nausea - psychology | Neoplasms - drug therapy | Vomiting, Anticipatory - psychology | Animals | Antineoplastic Agents - adverse effects | Nausea - therapy | Antiemetics - therapeutic use | Conditioning, Classical | Adult | Benzodiazepines - therapeutic use | Behavior Therapy - methods | Chemotherapy | Nausea | Gastrointestinal agents | Cancer | Psychological aspects | Preventive medicine | Vomiting | Anticipatory nausea | vomiting
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Opioid induced nausea and vomiting
by Smith, Howard S and Laufer, Andras
European Journal of Pharmacology, ISSN 0014-2999, 01/2014, Volume 722, Issue 1, pp. 67 - 78
Opioids are broad spectrum analgesics that are an integral part of the therapeutic armamentarium to combat pain in the palliative care population.... 
Moxduo | Olanzapine | Vomiting | NK-1 | Opioids | Nausea | Antagonists | Tapentadol | CHEMOTHERAPY-INDUCED NAUSEA | LOW-BACK-PAIN | PATIENT-CONTROLLED ANALGESIA | RECEIVING EPIDURAL MORPHINE | GUINEA-PIG BRAIN | CONTROLLED PHASE-III | PREVENTING POSTOPERATIVE NAUSEA | TAPENTADOL IMMEDIATE-RELEASE | INDUCED BOWEL DYSFUNCTION | DORSAL MOTOR NUCLEUS | PHARMACOLOGY & PHARMACY | Pharmacogenetics | Nausea - chemically induced | Humans | Neurotransmitter Agents - metabolism | Nausea - physiopathology | Vomiting - drug therapy | Vomiting - chemically induced | Analgesics, Opioid - adverse effects | Animals | Antiemetics - therapeutic use | Nausea - metabolism | Nausea - drug therapy | Vomiting - physiopathology | Vomiting - metabolism | Antiemetics - pharmacology | Gastrointestinal agents | Health aspects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Effect of selective inhibition of monoacylglycerol lipase (MAGL) on acute nausea, anticipatory nausea, and vomiting in rats and Suncus murinus
by Parker, Linda A and Parker, Linda A and Niphakis, Micah J and Niphakis, Micah J and Downey, Rachel and Downey, Rachel and Limebeer, Cheryl L and Limebeer, Cheryl L and Rock, Erin M and Rock, Erin M and Sticht, Martin A and Sticht, Martin A and Morris, Heather and Morris, Heather and Abdullah, Rehab A and Abdullah, Rehab A and Lichtman, Aron H and Lichtman, Aron H and Cravatt, Benjamin F and Cravatt, Benjamin F
Psychopharmacology, ISSN 0033-3158, 2015, Volume 232, Issue 3, pp. 583 - 593
To determine the role of the endocannabinoid, 2-arachodonyl glycerol (2-AG), in the regulation of nausea and vomiting. We evaluated the effectiveness of the... 
Rat | Vomiting | 2-AG | Conditioned response | ABHD6 | MAGL | Nausea | Shrew | ABPP | Gaping | LITHIUM-PAIRED CONTEXT | INDUCED BEHAVIOR | CHEMOTHERAPY-INDUCED NAUSEA | PSYCHIATRY | BRAIN-STEM | NEUROSCIENCES | CANNABINOID RECEPTOR-TYPE-1 | FAAH INHIBITOR | PHARMACOLOGY & PHARMACY | ANIMAL-MODEL | TASTE AVOIDANCE | EMESIS | CB1 RECEPTORS | Monoacylglycerol Lipases - antagonists & inhibitors | Rats | Male | Succinimides - pharmacology | Carbamates - administration & dosage | Vomiting - drug therapy | Rats, Sprague-Dawley | Animals | Shrews | Female | Succinimides - administration & dosage | Nausea - drug therapy | Carbamates - pharmacology | Disease Models, Animal | Care and treatment | Research | Lipase | Health aspects | Inhibitor drugs | Small mammals | Psychopharmacology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Prevention of chemotherapy-induced nausea: the role of neurokinin-1 (NK1) receptor antagonists
by Bošnjak, Snežana M and Gralla, Richard J and Schwartzberg, Lee
Supportive Care in Cancer, ISSN 0941-4355, 5/2017, Volume 25, Issue 5, pp. 1661 - 1671
Chemotherapy-induced nausea (CIN) has a significant negative impact on the quality of life of cancer patients. The use of 5-hydroxytryptamine-3 (5-HT3)... 
Chemotherapy-induced nausea and vomiting (CINV) | Pain Medicine | Nursing | Rehabilitation Medicine | Medicine & Public Health | Nursing Research | NK 1 receptor antagonist | Chemotherapy-induced nausea (CIN) | Oncology | Antiemetic guidelines | receptor antagonist | PALONOSETRON NEPA | PHASE-III | ANTIEMETIC THERAPY | INDUCED DELAYED EMESIS | ONCOLOGY | MODERATELY EMETOGENIC CHEMOTHERAPY | HEALTH CARE SCIENCES & SERVICES | DOUBLE-BLIND | REHABILITATION | FIXED-DOSE COMBINATION | RADIOTHERAPY-INDUCED NAUSEA | PLACEBO-CONTROLLED TRIAL | QUALITY-OF-LIFE | NK1 receptor antagonist | Vomiting - chemically induced | Nausea - chemically induced | Antineoplastic Agents - adverse effects | Antiemetics - therapeutic use | Humans | Neurokinin-1 Receptor Antagonists - therapeutic use | Quality of Life - psychology | Prevention | Medical colleges | Chemotherapy | Dexamethasone | Nausea | Patient compliance | Cancer | Side effects | Antagonist drugs | Clinical outcomes | Meta-analysis | Review
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Regulation of nausea and vomiting by cannabinoids
by Parker, Linda A and Rock, Erin M and Limebeer, Cheryl L
British Journal of Pharmacology, ISSN 0007-1188, 08/2011, Volume 163, Issue 7, pp. 1411 - 1422
Considerable evidence demonstrates that manipulation of the endocannabinoid system regulates nausea and vomiting in humans and other animals. The anti‐emetic... 
cannabidiol | gaping | taste reactivity | serotonin | 5‐hydroxytryptamine | cannabinoid | conditioned disgust | emesis | vomiting | nausea | 5-hydroxytryptamine | LITHIUM-PAIRED CONTEXT | CHEMOTHERAPY-INDUCED NAUSEA | SUNCUS-MURINUS | HOUSE MUSK SHREW | RANDOMIZED CONTROLLED-TRIAL | SOLITARY TRACT NUCLEUS | CONDITIONED REJECTION REACTIONS | TASTE REACTIVITY TEST | PHARMACOLOGY & PHARMACY | M-RECEPTOR ANTAGONISM | CISPLATIN-INDUCED EMESIS | Cannabinoids - therapeutic use | Animals | Receptor, Cannabinoid, CB1 - agonists | Antiemetics - therapeutic use | Humans | Nausea - metabolism | Vomiting - drug therapy | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Nausea - drug therapy | Vomiting - metabolism | Antiemetics - pharmacology | Cannabinoids - pharmacology | Vomiting | Nausea | Index Medicus | Reviews
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Efficacy of palonosetron in postoperative nausea and vomiting (PONV)—a meta-analysis
by Singh, Preet Mohinder, MD, DNB and Borle, Anuradha, MD and Gouda, Divakara and Makkar, Jeetinder Kaur, MD and Arora, Mahesh K., MD and Trikha, Anjan, MD and Sinha, Ashish, MD, MBA and Goudra, Basavana, MD, FRCA, FCARCSI
Journal of Clinical Anesthesia, ISSN 0952-8180, 2016, Volume 34, pp. 459 - 482
Abstract Introduction Palonosetron is a second-generation 5-HT3 receptor antagonist with proposed higher efficacy and sustained action for prophylaxis of... 
Anesthesia & Perioperative Care | Pain Medicine | Palonosetron vs placebo or ramosetron or granisetron or ondansetron | Palonosetron for delayed PONV | Palonosetron for PONV | Palonosetron meta-analysis for PONV | SURGERY | EMETOGENIC CHEMOTHERAPY | PLACEBO | CHEMOTHERAPY-INDUCED NAUSEA | SAFETY | 5-HT3 RECEPTOR ANTAGONISTS | ONDANSETRON | DOUBLE-BLIND-TRIAL | GRANISETRON | CLINICAL-TRIALS | ANESTHESIOLOGY | Granisetron - adverse effects | Isoquinolines - adverse effects | Humans | Serotonin Antagonists - therapeutic use | Treatment Outcome | Anesthesia, General - adverse effects | Postoperative Nausea and Vomiting - prevention & control | Randomized Controlled Trials as Topic | Quinuclidines - therapeutic use | Serotonin Antagonists - adverse effects | Ondansetron - therapeutic use | Antiemetics - therapeutic use | Isoquinolines - therapeutic use | Adult | Antiemetics - adverse effects | Ondansetron - adverse effects | Benzimidazoles - adverse effects | Granisetron - therapeutic use | Quinuclidines - adverse effects | Benzimidazoles - therapeutic use | Analysis | Nausea | Postoperative period | Headaches | Clinical trials | FDA approval | Meta-analysis | Studies | Chemotherapy | Researchers | Vomiting | Surgery | Population | Patient satisfaction | Constipation | Drug dosages
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Chronic nausea and vomiting: Evaluation and treatment
by Lacy, Brian E and Parkman, Henry P and Camilleri, Michael
American Journal of Gastroenterology, ISSN 0002-9270, 05/2018, Volume 113, Issue 5, pp. 647 - 659
Nausea is an uneasy feeling in the stomach while vomiting refers to the forceful expulsion of gastric contents. Chronic nausea and vomiting represent a diverse... 
GASTRIC-EMPTYING SCINTIGRAPHY | REFRACTORY DIABETIC GASTROPARESIS | CONTRAST BARIUM MEAL | TRICYCLIC ANTIDEPRESSANTS | CHEMOTHERAPY-INDUCED NAUSEA | FUNCTIONAL DYSPEPSIA | ENDOLUMINAL IMAGE-ANALYSIS | SMALL-BOWEL OBSTRUCTION | IDIOPATHIC GASTROPARESIS | QUALITY-OF-LIFE | GASTROENTEROLOGY & HEPATOLOGY | Prevalence | Humans | Cost of Illness | Chronic Disease - epidemiology | Chronic Disease - economics | Nausea - diagnosis | Nausea - epidemiology | Nausea - etiology | Vomiting - diagnosis | Nausea - therapy | Chronic Disease - therapy | Quality of Life | Vomiting - etiology | Vomiting - therapy | Vomiting - epidemiology | Vomiting | Nausea
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Improved Prevention of Moderately Emetogenic Chemotherapy-Induced Nausea and Vomiting with Palonosetron, a Pharmacologically Novel 5-HT3 Receptor Antagonist: Results of a Phase III, Single-Dose Trial Versus Dolasetron
by Eisenberg, Peter and Figueroa-Vadillo, Jazmin and Zamora, Rosalio and Charu, Veena and Hajdenberg, Julio and Cartmell, Alan and Macciocchi, Alberto and Grunberg, Steven and 99-04 Palonosetron Study Group
Cancer, ISSN 0008-543X, 12/2003, Volume 98, Issue 11, pp. 2473 - 2482
BACKGROUND. Palonosetron, a highly selective and potent 5-HT3 receptor antagonist with a strong binding affinity and a long plasma elimination half-life... 
Dolasetron | 5-HT | receptor antagonist | Antiemetic | Chemotherapy-induced nausea and vomiting | Palonosetron | SELECTIVE ANTAGONIST | POTENT | ONCOLOGY | dolasetron | antiemetic | palonosetron | 5-HT3 receptor antagonist | chemotherapy-induced nausea and vomiting | Quinolizines - therapeutic use | Isoquinolines - adverse effects | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Isoquinolines - pharmacology | Quinuclidines - therapeutic use | Antiemetics - therapeutic use | Adult | Antiemetics - adverse effects | Female | Indoles - pharmacology | Quinolizines - adverse effects | Vomiting - prevention & control | Quinuclidines - adverse effects | Severity of Illness Index | Double-Blind Method | Quinuclidines - pharmacology | Treatment Outcome | Quinolizines - pharmacology | Neoplasms - drug therapy | Vomiting - chemically induced | Indoles - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Isoquinolines - therapeutic use | Indoles - therapeutic use | Aged | Infusions, Intravenous | Antiemetics - pharmacology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Nausea still the poor relation in antiemetic therapy? The impact on cancer patients’ quality of life and psychological adjustment of nausea, vomiting and appetite loss, individually and concurrently as part of a symptom cluster
by Pirri, Carlo and Bayliss, Evan and Trotter, James and Olver, Ian N and Katris, Paul and Drummond, Peter and Bennett, Robert
Supportive Care in Cancer, ISSN 0941-4355, 3/2013, Volume 21, Issue 3, pp. 735 - 748
Despite significant antiemetic advances, almost 50 % of treated cancer patients still experience nausea and vomiting (N&V). The goal of antiemetic... 
Psychological | Anorexia | Rehabilitation Medicine | Oncology | Nausea | Radiotherapy | Nursing Management/Nursing Research | Quality of life | Pain Medicine | Chemotherapy | Nursing | Medicine & Public Health | Vomiting | Symptom cluster | Surgery | Non-pharmacological | Cancer | POSTCHEMOTHERAPY NAUSEA | CHEMOTHERAPY-INDUCED NAUSEA | BREAST-CANCER | ONCOLOGY | HEALTH CARE SCIENCES & SERVICES | REHABILITATION | OLANZAPINE | EMESIS | ELDERLY-PATIENTS | Prognosis | Prospective Studies | Nausea - chemically induced | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Nausea - psychology | Incidence | Young Adult | Time Factors | Antineoplastic Agents - adverse effects | Antiemetics - therapeutic use | Adult | Female | Vomiting - prevention & control | Appetite - drug effects | Factor Analysis, Statistical | Evidence-Based Medicine | Neoplasms - drug therapy | Nausea - prevention & control | Vomiting - chemically induced | Adolescent | Vomiting - psychology | Quality of Life | Longitudinal Studies | Antiemetics - pharmacology | Cancer patients | Care and treatment | Analysis | Psychological aspects | Side effects | Cancer therapies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Effect of nerve electrical stimulation for treating chemotherapy-induced nausea and vomiting in patients with advanced gastric cancer: A randomized controlled trial
by Guo, Wen-Cheng and Wang, Fang
Medicine, ISSN 0025-7974, 12/2018, Volume 97, Issue 51, p. e13620
Background: This randomized controlled trial evaluated the effectiveness of nerve electrical stimulation (NES) for the treatment of chemotherapy-induced nausea... 
effectiveness | MEDICINE, GENERAL & INTERNAL | EFFICACY | SAFETY | DOUBLE-BLIND | PREVENTION | APREPITANT | advanced gastric cancer | adverse event | MODERATELY EMETOGENIC CHEMOTHERAPIES | chemotherapy-induced nausea and vomiting | nerve electrical stimulation | Appetite | Severity of Illness Index | Transcutaneous Electric Nerve Stimulation | Nausea - chemically induced | Humans | Middle Aged | Male | Treatment Outcome | Stomach Neoplasms - drug therapy | Vomiting - chemically induced | Electric Stimulation Therapy - methods | Antineoplastic Agents - adverse effects | Nausea - therapy | Adult | Female | Aged | Vomiting - therapy | Treatment outcome | Usage | Care and treatment | Nausea | Research | Stomach cancer | Risk factors | Complications and side effects | Chemotherapy | Vomiting | Analysis | Neural stimulation | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text The cellular mechanisms of the antiemetic action of dexamethasone and related glucocorticoids against vomiting
by Chu, Chin-Chen and Hsing, Chung-Hsi and Shieh, Ja-Ping and Chien, Chih-Chiang and Ho, Chiu-Ming and Wang, Jhi-Joung
European Journal of Pharmacology, ISSN 0014-2999, 01/2014, Volume 722, Issue 1, pp. 48 - 54
Glucocorticoids, used primarily as anti-allergic and anti-inflammatory drugs, are also effective, alone or combined with other antiemetics, for preventing... 
CINV | RINV | PONV | Dexamethasone | Glucocorticoids | Emesis | RISK-FACTORS | CHEMOTHERAPY-INDUCED NAUSEA | CONSENSUS CONFERENCE | RADIATION-INDUCED EMESIS | RECEIVING CANCER-CHEMOTHERAPY | LAPAROSCOPIC CHOLECYSTECTOMY | AREA POSTREMA | POSTOPERATIVE NAUSEA | PHARMACOLOGY & PHARMACY | RADIOTHERAPY-INDUCED NAUSEA | MOLECULAR-MECHANISMS | Glucocorticoids - therapeutic use | Nausea - chemically induced | Nausea - microbiology | Humans | Vomiting - drug therapy | Vomiting - chemically induced | Dexamethasone - therapeutic use | Dexamethasone - pharmacology | Nausea - etiology | Antiemetics - therapeutic use | Nausea - metabolism | Glucocorticoids - pharmacology | Vomiting - etiology | Nausea - drug therapy | Vomiting - metabolism | Antiemetics - pharmacology | Proteins | Chemotherapy | Gastrointestinal agents | Central nervous system depressants | Nausea | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights